Amrita Pati

Executive Director of Computational Biology in Precision Medicine · Amgen Inc. · company speakers →

Amrita Pati is Executive Director of Computational Biology in Precision Medicine at Amgen, where she leads efforts to integrate high-content clinical and biomarker data to accelerate therapeutic development across oncology, cardiometabolic diseases, inflammation, and rare disease. Her expertise spans multi-modal omics, liquid biopsy, AI/ML, and predictive analytics in Rx/Dx development. She oversees global biomarker and computational biology initiatives, integrating multi-omics, liquid biopsy, and advanced analytics to translate complex biology into actionable insights. Prior to Amgen, she directed algorithm development for oncology and NIPT NGS assays at Roche Sequencing and led the OMICs Analysis Group at the DOE Joint Genome Institute, where her team advanced multi-omics analyses for natural product biosynthesis and microbial genomics. Dr. Pati has authored more than 300 scientific publications and has contributed to the development and application of computational biology methods across diverse therapeutic areas. She holds a PhD in Computer Science with a specialization in Computational Biology and Bioinformatics from Virginia Tech.

Is this you? Claim this profile →